Disease areas:
  • brain
Last updated:
Author(s):
Adil Supiyev, Robert Karlsson, Yunzhang Wang, Elise Koch, Sara Hägg, Karolina Kauppi
Publish date:
22 February 2023
Journal:
Neurobiology of Aging
PubMed ID:
36965205

Abstract

Apolipoprotein E (APOE) ε4, the strongest genetic risk factor for late onset Alzheimer’s disease (LOAD), has been associated with cognitive decline independent from AD pathology, but the role for other LOAD risk genes in normal cognitive aging is less studied. We examined the effect of APOE ε4 and several different polygenic risk scores (PRS) for LOAD on cognitive level and decline in aging, using longitudinal data from the UK Biobank. While PRS-LOAD including all variants (except APOE) predicted cognitive level, APOE ε4 and PRS-LOAD based on 17 non-APOE gene variants with strong association to AD (p < 5e-8) predicted age-related decline in verbal numeric reasoning. The effect on decline were partly driven by 4 variants involved in the immune system. Those variants also predicted serum levels of the inflammatory marker C-reactive protein (CRP), but CRP did not mediate the effect on decline. Those findings suggest genetic variations in immune functions play a role in aspects of cognitive aging that may be independent of LOAD pathology as well as systemic inflammation measured by CRP.

Related projects

This research will identify metabolic, genetic and lifestyle measures that predict, and may determine, the onset of various age-related degenerative diseases. We will establish studies…

Institution:
Karolinska Institutet, Sweden

All projects